Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY: DGX )

159.37 +3.17 (+2.03%)
Official Closing Price Updated: 6:30 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 944,009
Open 155.90
Bid (Size) 153.68 (2)
Ask (Size) 161.86 (1)
Prev. Close 156.20
Today's Range 155.78 - 160.48
52wk Range 123.04 - 160.95
Shares Outstanding 122,180,759
Dividend Yield 1.78%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact
LabCorp Q3 2024 EPS beats expectations at $3.50, with 7.4% revenue growth to $3.28B. Adjusted EPS guidance revised due to weather. 
Via Benzinga
Topics Earnings
Exposures Financial
This Snap Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga

Performance

YTD
+13.17%
+13.17%
1 Month
+6.95%
+6.95%
3 Month
+6.74%
+6.74%
6 Month
+15.14%
+15.14%
1 Year
+21.07%
+21.07%

More News

Read More
What Analysts Are Saying About Quest Diagnostics Stock
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics
Via Benzinga
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Earnings Preview: Quest Diagnostics
Via Benzinga
Looking Into Quest Diagnostics's Recent Short Interest
Via Benzinga
Decoding 7 Analyst Evaluations For Quest Diagnostics
Via Benzinga
What Analysts Are Saying About Quest Diagnostics Stock
Via Benzinga
Quest Diagnostics CEO Touts 'New Customer Wins' In Q3, Expects Earnings Growth In 2025
Via Benzinga
Uber To Rally Over 33%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
Via Benzinga
8 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
Via Benzinga
Uncovering Dividend Opportunities with NYSE:DGX.
Via Chartmill
5 Analysts Assess Quest Diagnostics: What You Need To Know
Via Benzinga
Quest Diagnostics' Q2 Earnings Performance Suggests Stable Stock, Modest Growth Ahead, Analyst Says
Via Benzinga
Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday?
Via Benzinga
DGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Cracking The Code: Understanding Analyst Reviews For Quest Diagnostics
Via Benzinga
US Stock Futures Little Changed As Traders Brace For Q2 Reports From Alphabet, Tesla: 'There Remains Strong Fundamental Support For Large Caps,' Says Economist
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer Therapy
From Lisata Therapeutics, Inc.; Quest Diagnostics, Haystack Oncology
Via GlobeNewswire
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
Via Benzinga
EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy
Via Benzinga
S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.